Sex Bias in Infectious Disease Epidemiology: Patterns and Processes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Guerra Silveira, Felipe ^a,b   Abad Franch, Fernando ^a  

^a INSTITUTO LEÔNIDAS E MARIA DEANE   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BEHAVIOR; CHILD; DENGUE VIRUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; EPIDEMIC MENINGITIS; FEMALE; GENDER BIAS; GENETIC VARIABILITY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INCIDENCE; INFANT; INFECTION; LEISHMANIA; LEISHMANIA INFANTUM; LEPROMATOUS LEPROSY; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; PREDICTIVE VALIDITY; PRESCHOOL CHILD; PREVALENCE; SALMONELLA TYPHI; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHOOL CHILD; SEX DIFFERENCE; SKIN LEISHMANIASIS; TUBERCULOID LEPROSY; TYPHOID FEVER; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BRAZIL; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ODDS RATIO; SEX FACTORS; YOUNG ADULT;

SCHISTOSOMA;

EID: 84876544047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062390     Document Type: Article

References (128)

1. Wizeman TM, Pardue M-L, editors (2001) Exploring the Biological Contributions to Human Health: Does Sex Matter? Washington, DC: National Academy Press. 288 p.
2. World Health Organization (2007) Addressing Sex and Gender in Epidemic-Prone Infectious Diseases. Geneva: WHO. iv +40 p.
3. Brabin L, Brabin BJ, (1992) Parasitic infections in women and their consequences. Adv Parasitol 31: 1-81.
4. Tolhurst R, Koning K, Price J, Kemp J, Theobald S, et al. (2002) The challenge of infectious disease: time to take gender into account. J Health Manage 4: 135-151.
5. Sen G, Östlin P, George A (Women and Gender Equity Knowledge Network) (2007) Unequal, Unfair, Ineffective and Inefficient - Gender Inequity in Health: Why it Exists and How We Can Change it. Final Report to the WHO Commission on Social Determinants of Health. WHO website. Available: http://www.who.int/social_determinants/resources/csdh_media/wgekn_final_report_07.pdf. Accessed 2011 Jun 19.
6. Zuk M, McKean KA, (1996) Sex differences in parasite infections: patterns and processes. Int J Parasitol 26: 1009-1024.
7. Sheridan LAD, Poulin R, Ward DF, Zuk M, (2000) Sex differences in parasitic infections among arthropod hosts: is there a male bias? Oikos 88: 327-334.
8. Moore SL, Wilson KW, (2002) Parasites as a viability cost of sexual selection in natural populations of mammals. Science 297: 2015-2017.
9. Klein SL, (2004) Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol 26: 247-264.
10. Roberts ML, Buchanan KL, Evans MR, (2004) Testing the immunocompetence handicap hypothesis: a review of the evidence. Anim Behav 68: 227-239.
11. Roberts CW, Walker W, Alexander J, (2001) Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 14: 476-488.
12. Bouman A, Heineman MJ, Faas MM, (2005) Sex hormones and the immune response in humans. Human Reprod Update 11: 411-423.
13. Klein SL, Jedlicka A, Pekosz A, (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10: 338-349.
14. Muehlenbein MP, Bribiescas RG, (2005) Testosterone-mediated immune functions and male life histories. Am J Hum Biol 17: 527-558.
15. Fish EN, (2008) The X-files in immunity: sex-based differences predispose immune responses. Nature Rev Immunol 8: 737-744.
16. Klein SL, Roberts CW, editors (2010) Sex Hormones and Immunity to Infection. Berlin: Springer Verlag. x+319 p.
17. Ober C, Loisel DA, Gilad Y, (2008) Sex-specific genetic architecture of human disease. Nature Rev Genet 9: 911-922.
18. Restif O, Amos W, (2010) The evolution of sex-specific immune defences. Proc R Soc B 277: 2247-2255.
19. Brei B, Fish D, (2003) Comment on "Parasites as a viability cost of sexual selection in natural populations of mammals". Science 300: 55a.
20. Krieger N, (2003) Genders, sexes, and health: what are the connections - and why does it matter? Int J Epidemiol 32: 652-657.
21. World Health Organization (2009) Women and Health: Today's Evidence Tomorrow's Agenda. Geneva: WHO. ix +91 p.
22. Owens IPF, (2002) Sex differences in mortality rates. Science 297: 2008-2009.
23. Garenne M, (1994) Sex differences in measles mortality: a world review. Int J Epidemiol 23: 632-642.
24. Crabtree TD, Pelletier SJ, Gleason TG, Pruett TL, Sawyer RG, (1999) Gender-dependent differences in outcome after the treatment of infection in hospitalized patients. JAMA 282: 2143-2148.
25. Acuna-Soto R, Maguire JH, Wirth DF, (2000) Gender distribution in asymptomatic and invasive amebiasis. Am J Gastroenterol 95: 1277-1283.
26. Varkevisser CM, Lever P, Alubo O, Burathoki K, Idawani C, et al. (2009) Gender and leprosy: cases studies in Indonesia, Nigeria, Nepal, and Brazil. Lepr Rev 80: 65-76.
27. Neyrolles O, Quintana-Murci L, (2009) Sexual inequality in tuberculosis. PLoS Med 6: e1000199.
28. Labrie F, Cusan L, Gomez JL, Martel C, Bérubé R, et al. (2009) Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer. J Steroid Biochem Mol Biol 113: 52-56.
29. Guzmán MG, Kourí G, (2002) Dengue: and update. Lancet Infect Dis 2: 33-42.
30. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712-722.
31. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
32. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR, (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Syn Meth 1: 97-111.
33. Cohen J, (1994) The Earth is round (p<.05). Am Psychol 49: 997-1003.
34. Brown LD, Cai TT, DasGupta A, (2001) Interval estimation for a binomial proportion. Stat Sci 16: 101-117.
35. Naiff RD, Barrett TV, Arias JR, Naiff MF, (1988) Encuesta epidemiológica de histoplasmosis, paracoccidioidomicosis y leishmaniasis mediante pruebas cutáneas. Bol Of Sanit Panam 140: 35-50.
36. Gomes AC, Yamamoto YI, Capinzaiki AN, Amaral NMM, Guimarães AJG, (1992) Aspectos ecológicos da Leishmaniose Tegumentar Americana 9. Prevalência/incidência da infecção humana nos municípios de Pedro de Toledo e Miracatu, São Paulo, Brasil. Rev Inst Med Trop São Paulo 34: 149-158.
37. Coimbra CEA Jr, Santos RV, do Valle ACF, (1996) Cutaneous leishmaniasis in Tupí-Mondé Amerindians from the Brazilian Amazonia. Acta Trop 61: 201-211.
38. Brandão-Filho SP, Campbell-Lendrum D, Brito MEF, Shaw JJ, Davies CR, (1999) Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil. Trans R Soc Trop Med Hyg 93: 488-494.
39. Oliveira CCG, Lacerda HG, Martins DRM, Barbosa JDA, Monteiro GR, et al. (2004) Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface. Acta Trop 90: 155-162.
40. Muñoz G, Davies CR, (2006) Leishmania panamensis transmission in the domestic environment: the results of a prospective epidemiological survey in Santander, Colombia. Biomédica 26(Suppl (1) (): 131-144.
41. Nascimento MD, Souza EC, Silva LM, Leal PC, Cantanhede KL, et al. (2005) Prevalência de infecção por Leishmania chagasi utilizando os métodos de ELISA (rK39 e CRUDE) e intradermorreação de Montenegro em área endêmica do Maranhão, Brasil. Cad Saúde Pública 21: 1801-1807.
42. Moreno EC, Melo MN, Genaro O, Lambertucci JR, Serufo JC, et al. (2005) Risk factors for Leishmania chagasi infection in an urban area of Minas Gerais State. Rev Soc Bras Med Trop 38: 456-463.
43. Gouvêa MV, Werneck GL, Costa CH, de Amorim Carvalho FA, (2007) Factors associated to Montenegro skin test positivity in Teresina, Brazil. Acta Trop 104: 99-107.
44. Barão SC, de Fonseca Camargo-Neves VL, Resende MR, da Silva LJ, (2007) Human asymptomatic infection in visceral leishmaniasis: a seroprevalence study in an urban area of low endemicity. Preliminary results. Am J Trop Med Hyg 77: 1051-1053.
45. Oliveira AL, Paniago AM, Sanches MA, Dorval ME, Oshiro ET, et al. (2008) Asymptomatic infection in family contacts of patients with human visceral leishmaniasis in Três Lagoas, Mato Grosso do Sul State, Brazil. Cad Saúde Pública 24: 2827-2833.
46. de Gouvêa Viana L, de Assis TS, Orsini M, da Silva AR, de Souza GF, et al. (2008) Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles. Trans R Soc Trop Med Hyg 102: 548-555.
47. Falqueto A, Ferreira AL, dos Santos CB, Porrozzi R, da Costa MV, et al. (2009) Cross-sectional and longitudinal epidemiologic surveys of human and canine Leishmania infantum visceral infections in an endemic rural area of southeast Brazil (Pancas, Espírito Santo). Am J Trop Med Hyg 80: 559-565.
48. Crescente JA, Silveira FT, Lainson R, Gomes CM, Laurenti MD, et al. (2009) A cross-sectional study on the clinical and immunological spectrum of human Leishmania (L.) infantum chagasi infection in the Brazilian Amazon region. Trans R Soc Trop Med Hyg 103: 1250-1256.
49. Silveira FT, Lainson R, Pereira EA, de Souza AA, Campos MB, et al. (2009) A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence. Parasitol Res 104: 559-567.
50. Fakhar M, Motazedian MH, Hatam GR, Asgari Q, Kalantari M, et al. (2008) Asymptomatic human carriers of Leishmania infantum: possible reservoirs for Mediterranean visceral leishmaniasis in southern Iran. Ann Trop Med Parasitol 102: 577-583.
51. Faye B, Bucheton B, Bañuls AL, Senghor MW, Niang AA, et al. (2011) Seroprevalence of Leishmania infantum in a rural area of Senegal: analysis of risk factors involved in transmission to humans. Trans R Soc Trop Med Hyg 105: 333-340.
52. Scarlata F, Vitale F, Saporito L, Reale S, Vecchi VL, et al. (2008) Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 102: 394-396.
53. Garrote JI, Gutiérrez MP, Izquierdo RL, Dueñas MA, Zarzosa P, et al. (2004) Seroepidemiologic study of Leishmania infantum infection in Castilla-León, Spain. Am J Trop Med Hyg 71: 403-406.
54. Agrela IF, Sánchez E, (2009) Prevalencia de la infección por Leishmania spp. en un área periurbana de Altagracia de Orituco, estado Guárico, Venezuela. Bol Mal Salud Amb XLIX: 107-116.
55. Diza E, Kansouzidou A, Gerou S, Vezyri E, Metallidis S, et al. (2008) Leishmaniases in Northern Greece: seroprevalence of the infection and incidence of the disease during the period 2001-2006. Eur J Clin Microbiol Infect Dis 27: 997-1003.
56. Camargo-Neves VL, Kanamura HY, Vellosa SA, Gargioni C, Dias LC (1998) IgM antibodies to Schistosoma mansoni gut-associated antigens for the study of schistosomiasis transmission in Ribeirão Pires, São Paulo. Mem Inst Oswaldo Cruz (Suppl. 1): 273-278.
57. Lima VL, Guercio VM, Rangel O, Kanamura HY, Dias LC (1998) Immunofluorescence test on Schistosoma mansoni worm paraffin sections (IgM-IFT) for the study of schistosomiasis transmission in Campinas, São Paulo, Brazil. Mem Inst Oswaldo Cruz (Suppl. 1): 283-287.
58. Zacharias F, de Carvalho ME, Gargioni C, Teles HM, Ferreira CS, et al. (2002) Schistosomiasis mansoni in Bananal (State of São Paulo, Brazil). III. Seroepidemiological studies in the Palha District. Mem Inst Oswaldo Cruz (Suppl. 1): 19-22.
59. Hillyer GV, Tsang VC, Vivas-Gonzalez BE, Noh J, Ahn LH, et al. (1999) Age-specific decrease in seroprevalence of schistosomiasis in Puerto Rico. Am J Trop Med Hyg 60: 313-318.
60. Hillyer GV, Soler de Galanes M, (1999) Seroepidemiology of schistosomiasis in Puerto Rico: evidence for vanishing endemicity. Am J Trop Med Hyg 60: 827-830.
61. Rodrigues RN, Murta C, Teixeira Júnior MA, Cury GC, Rocha MO, (1995) Clinical-epidemiologic study of schistosomiasis mansoni in Ponte do Pasmado, a village in the municipality of Itinga, state of Minas Gerais, Brazil, 1992. Rev Inst Med Trop São Paulo 37: 81-85.
62. Guimarães ICS, Tavares-Neto J, (2006) Transmissão urbana de esquistossomose em crianças de um bairro de Salvador, Bahia. Rev Soc Bras Med Trop 39: 451-455.
63. Firmo JO, Lima Costa MF, Guerra HL, Rocha RS, (1996) Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection. Int J Epidemiol 25: 1292-1300.
64. Coura-Filho P, Farah MW, Rezende DF, Lamartine SS, Carvalho OS, et al. (1995) Determinantes ambientais e sociais da esquistossomose mansoni em Ravena, Minas Gerais, Brasil. Cad Saúde Pública 11: 254-265.
65. Lima e Costa MF, Rocha RS, Leite ML, Carneiro RG, Colley D, et al. (1991) A multivariate analysis of socio-demographic factors, water contact patterns and Schistosoma mansoni infection in an endemic area in Brazil. Rev Inst Med Trop São Paulo 33: 58-63.
66. Barreto ML, (1991) Geographical and socioeconomic factors relating to the distribution of Schistosoma mansoni infection in an urban area of north-east Brazil. Bull World Health Organ 69: 93-102.
67. da Silva AA, Cutrim RN, de Britto e Alves MT, Coimbra LC, Tonial SR, et al. (1997) Water-contact patterns and risk factors for Schistosoma mansoni infection in a rural village of northeast Brazil. Rev Inst Med Trop São Paulo 9: 91-96.
68. Coelho KR (2010) Infecção pelo Schistosoma mansoni em Estudantes como Indicador da Infecção na População em Área Rural de Alta Prevalência. MSc Thesis. Belo Horizonte: Universidade Federal de Minas Gerais. 97 p.
69. Roth VR, Garrett DO, Laserson KF, Starling CE, Kritski AL, et al. (2005) A multicenter evaluation of tuberculin skin test positivity and conversion among health care workers in Brazilian hospitals. Int J Tuberc Lung Dis 9: 1335-1342.
70. Teixeira EG, Menzies D, Comstock GW, Cunha AJ, Kritski AL, et al. (2005) Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis 9: 841-847.
71. Rabahi MF, Junqueira-Kipnis AP, Dos Reis MC, Oelemann W, Conde MB, (2007) Humoral response to HspX and GlcB to previous and recent infection by Mycobacterium tuberculosis. BMC Infect Dis 7: 148.
72. Cailleaux-Cezar M, de A Melo D, Xavier GM, de Salles CL, de Mello FC, et al. (2009) Tuberculosis incidence among contacts of active pulmonary tuberculosis. Int J Tuberc Lung Dis 13: 190-195.
73. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, et al. (2009) Analysis of discordance between the tuberculin skin test and the interferon-gamma release assay. Int J Tuberc Lung Dis 13: 446-453.
74. Brasil MTLRF, Oliveira LR, Melo CS, Nakamura PM, Rimoli NS, et al. (1998) Aplicação do teste Elisa anti-PGL-1 em localidade com alta endemicidade de hanseníase na região norte do estado de São Paulo. Hansen Int 230: 35-48.
75. Calado KLS, Vieira AG, Durães S, Bührer-Sékula S, Oliveira MLW-D-R (2005) Positividade sorológica antiPGL-I em contatos domiciliares e peridomiciliares de hanseníase em área urbana. An Bras Dermatol (Suppl. 3): S301-S306.
76. Andrade ARC, Grossi MAF, Bührer-Sékula S, Antunes CMF (2008) Soroprevalência do teste ML Flow em contatos de hanseníase de Minas Gerais. Rev Soc Bras Med Trop 41(Suppl. II): 56-59.
77. Grossi MA, Leboeuf MA, Andrade AR, Bührer-Sékula S, Antunes CM (2008) Fatores de risco para a soropositividade do ML Flow em pacientes com hanseníase. Rev Soc Bras Med Trop 41(Suppl. II): 39-44.
78. Ibekwe AC, Okonko IO, Onunkwo AU, Donbraye E, Babalola ET, et al. (2008) Baseline Salmonella agglutinin titres in apparently healthy freshmen in Awka, South Eastern, Nigeria. Sci Res Essays 3: 425-430.
79. Gupta A, My Thanh NT, Olsen SJ, Sivapalasingam S, My Trinh TT, et al. (2006) Evaluation of community-based serologic screening for identification of chronic Salmonella typhi carriers in Vietnam. Int J Infect Dis 10: 309-314.
80. Pereira MM, Andrade J, (1990) Human leptospirosis in a slum area in the city of Rio de Janeiro, Brazil - a serological and epidemiological study. Mem Inst Oswaldo Cruz 85: 47-52.
81. Aguiar DM, Cavalcante GT, Camargo LMA, Labruna MB, Vasconcellos SA, et al. (2007) Anti-Leptospira spp. and anti-Brucella spp. antibodies in humans from rural area of Monte Negro municipality, state of Rondônia, Brazilian Western Amazon. Braz J Microbiol 38: 93-96.
82. Lacerda HG, Monteiro GR, Oliveira CC, Suassuna FB, Queiroz JW, et al. (2008) Leptospirosis in a subsistence farming community in Brazil. Trans R Soc Trop Med Hyg 102: 1233-1238.
83. Reis RB, Ribeiro GS, Felzemburgh RD, Santana FS, Mohr S, et al. (2008) Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2: e228.
84. Caugant DA, Høiby EA, Magnus P, Scheel O, Hoel T, et al. (1994) Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol 32: 323-330.
85. Cartwright KA, Stuart JM, Jones DM, Noah ND, (1987) The Stonehouse survey: nasopharyngeal carriage of meningococci and Neisseria lactamica. Epidemiol Infect 99: 591-601.
86. Blackwell CC, Weir DM, James VS, Todd WT, Banatvala N, et al. (1990) Secretor status, smoking and carriage of Neisseria meningitidis. Epidemiol Infect 104: 203-209.
87. Imrey PB, Jackson LA, Ludwinski PH, England AC 3rd, Fella GA, et al (1995) Meningococcal carriage, alcohol consumption, and campus bar patronage in a serogroup C meningococcal disease outbreak. J Clin Microbiol 33: 3133-3137.
88. Olsen SF, Djurhuus B, Rasmussen K, Joensen HD, Larsen SO, et al. (1991) Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease. Epidemiol Infect 106: 445-457.
89. MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, et al. (2006) Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 12: 950-957.
90. Orr HJ, Gray SJ, Macdonald M, Stuart JM, (2003) Saliva and meningococcal transmission. Emerg Infect Dis 9: 1314-1315.
91. Tayal SC, Rashid S, Muttu KM, Hildreth AJ, (1997) Meningococcal carriage: prevalence and sex-related risk factors. J Infect 34: 101-105.
92. Gazi H, Surucuoglu S, Ozbakkaloglu B, Akcali S, Ozkutuk N, et al. (2004) Oropharyngeal carriage and penicillin resistance of Neisseria meningitidis in primary school children in Manisa, Turkey. Ann Acad Med Singapore 33: 758-762.
93. Patrick DM, Champagne S, Goh SH, Arsenault G, Thomas E, et al. (2003) Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin Infect Dis 37: 1183-1188.
94. Pavlopoulou ID, Daikos GL, Alexandrou H, Petridou E, Pangalis A, et al. (2004) Carriage of Neisseria meningitidis by Greek children: risk factors and strain characteristics. Clin Microbiol Infect 10: 137-142.
95. Bakir M, Yagci A, Ulger N, Akbenlioglu C, Ilki A, et al. (2001) Asymptomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: apropos of 1400 children sampled. Eur J Epidemiol 17: 1015-1018.
96. García Rojas A, Bordes Benítez A, Lafarga Capuz B, Vázquez Moreno J, López Villarrubia E, et al. (2000) Encuesta de portadores de Neisseria meningitidis en el área de salud de Gran Canaria. Rev Esp Salud Pública 74: 419-424.
97. Gilmore A, Jones G, Barker M, Soltanpoor N, Stuart JM, (1999) Meningococcal disease at the University of Southampton: outbreak investigation. Epidemiol Infect 123: 185-192.
98. Parodi V, Allende F, Torres E, Macedo M, Maglione R, et al. (1998) Portadores de Neisseria meningitidis en una población de Montevideo. Rev Méd Uruguay 14: 221-225.
99. Jackson LA, Alexander ER, DeBolt CA, Swenson PD, Boase J, et al. (1996) Evaluation of the use of mass chemoprophylaxis during a school outbreak of enzyme type 5 serogroup B meningococcal disease. Pediatr Infect Dis J 15: 992-998.
100. Fitzpatrick PE, Salmon RL, Hunter PR, Roberts RJ, Palmer SR, (2000) Risk factors for carriage of Neisseria meningitidis during an outbreak in Wales. Emerg Infect Dis 6: 65-69.
101. Clemens SA, da Fonseca JC, Azevedo T, Cavalcanti A, Silveira TR, et al. (2000) Soroprevalência para hepatite A e hepatite B em quatro centros no Brasil. Rev Soc Bras Med Trop 33: 1-10.
102. Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Gonçalves CS, et al. (2005) Prevalence of anti-hepatitis A antibodies in children of different socioeconomic conditions in Vila Velha, ES. Rev Soc Bras Med Trop 8: 285-289.
103. Kozlowski AG, Motta-Castro AR, Nascimento LB, Silva AM, Teles SA, et al. (2007) Prevalence of hepatitis A virus infection in Afro-Brazilian isolated communities in Central Brazil. Mem Inst Oswaldo Cruz 102: 121-123.
104. de Alencar Ximenes RA, Martelli CM, Merchán-Hamann E, Montarroyos UR, Braga MC, et al. (2008) Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol 7: 852-861.
105. Braga WS, Borges FG, Barros Júnior GM, Martinho AC, Rodrigues IS, et al. (2009) Prevalence of hepatitis A virus infection: the paradoxical example of isolated communities in the western Brazilian Amazon region. Rev Soc Bras Med Trop 42: 277-281.
106. Taghavi SA, Asl MKH, Talebzadeh M, Eshraghian A, (2011) Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon 11: 258-288.
107. Fix AD, Martin OS, Gallicchio L, Vial PA, Lagos R, (2002) Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg 66: 628-632.
108. Chung GE, Yim JY, Kim D, Lim SH, Park MJ, et al. (2001) Seroprevalence of hepatitis A and associated socioeconomic factors in young healthy Korean adults. Gut Liver 5: 88-92.
109. Verhoef L, Boot HJ, Koopmans M, Mollema L, Van Der Klis F, et al. (2011) Changing risk profile of hepatitis A in The Netherlands: a comparison of seroprevalence in 1995-1996 and 2006-2007. Epidemiol Infect 139: 1172-1180.
110. Vasconcelos PF, Mota K, Straatmann A, Santos-Torres S, da Rosa AP, et al. (2000) Epidemia de dengue em Ipupiara e Prado, Bahia. Inquérito soro-epidemiológico. Rev Soc Bras Med Trop 33: 61-67.
111. Vasconcelos PF, Lima JW, Raposo ML, Rodrigues SG, da Rosa JF, et al. (1999) Inquérito soro-epidemiológico na Ilha de São Luis durante epidemia de dengue no Maranhão. Rev Soc Bras Med Trop 32: 171-179.
112. da Cunha RV, Maspero RC, Miagostovich MP, de Araújo ES, da Luz C, et al. (1997) Dengue infection in Paracambi, State of Rio de Janeiro, 1990-1995. Rev Soc Bras Med Trop 30: 379-383.
113. Vasconcelos PF, Travassos da Rosa ES, Travassos da Rosa JFS, Freitas RB, Degallier N, et al. (1993) Epidemia de febre clássica de dengue causada pelo sorotipo 2 em Araguaina, Tocantins, Brazil. Rev Inst Med Trop São Paulo 35: 141-148.
114. Siqueira JB, Martelli CM, Maciel IJ, Oliveira RM, Ribeiro MG, et al. (2004) Household survey of dengue infection in central Brazil: spatial point pattern analysis and risk factors assessment. Am J Trop Med Hyg 71: 646-651.
115. Lima VL, Rangel O, Andrade VR, Silveira NY, Oliveira SS, et al. (2007) Dengue: inquérito populacional para pesquisa de anticorpos e vigilância virológica no Município de Campinas, São Paulo, Brasil. Cad Saúde Pública 23: 669-680.
116. Pessanha JEM, Caiaffa WT, Kroon EG, Proietti FA, (2010) Dengue em três distritos sanitários de Belo Horizonte, Brasil: inquérito soroepidemiológico de base populacional, 2006 a 2007. Rev Panam Salud Pública 27: 252-258.
117. Karlberg J, (1987) On the modelling of human growth. Stat Med 6: 185-192.
118. Travassos C, Viacava F, Pinheiro J, Brito A, (2002) Utilização dos serviços de saúde no Brasil: gênero, características familiares e condição social. Rev Panam Salud Pública 11: 365-373.
119. Drevenstedt GL, Crimmins EM, Vasunilashorn S, Finch CE, (2008) The rise and fall of excess male infant mortality. Proc Natl Acad Sci USA 105: 5016-5021.
120. Meller FO, Schäfer AA, (2011) Fatores associados ao tipo de parto em mulheres brasileiras: PNDS 2006. Cienc Saúde Coletiva 16: 3829-3835.
121. Walker SL, Lockwood DNJ, (2006) The clinical and immunological features of leprosy. Br Med Bull 77-78: 103-121.
122. Modlin RL, (2010) The innate immune response in leprosy. Curr Opin Immunol 22: 48-54.
123. Korenchevsky V, Dennison M, Schalit R, (1932) The response of castrated male rats to the injection of testicular hormone. Biochem J 26: 1306-1314.
124. Dougherty TF, (1952) Effect of hormones on lymphatic tissue. Physiol Rev 32: 379-401.
125. Grossman CJ, (1985) Interactions between the gonadal steroids and the immune system. Science 227: 257-261.
126. Frank C, Werber D, Cramer JP, Askar M, Faber M, et al. (2011) Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365: 1771-1780.
127. Blaser MJ, (2011) Deconstructing a lethal foodborne epidemic. N Engl J Med 365: 1835-1836.
128. Greinacher A, Friesecke S, Abel P, Dressel A, Stracke S, et al. (2011) Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial. Lancet 378: 1166-2273.